Tamara A. Sutfin

879 total citations
13 papers, 728 citations indexed

About

Tamara A. Sutfin is a scholar working on Pharmacology, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Tamara A. Sutfin has authored 13 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 4 papers in Oncology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Tamara A. Sutfin's work include Analytical Chemistry and Chromatography (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Tamara A. Sutfin is often cited by papers focused on Analytical Chemistry and Chromatography (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Tamara A. Sutfin collaborates with scholars based in United States, Sweden and China. Tamara A. Sutfin's co-authors include William J. Jusko, John A. Williams, Ronald W. Clark, Thomas Sand, Ronald T. Wester, Patricia G. Cosgrove, Michael E. Perlman, Eliot Sugarman, Roger B. Ruggeri and M J Bamberger and has published in prestigious journals such as Diabetes Care, Arteriosclerosis Thrombosis and Vascular Biology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Tamara A. Sutfin

13 papers receiving 673 citations

Peers

Countries citing papers authored by Tamara A. Sutfin

Since Specialization

Citations

This map shows the geographic impact of Tamara A. Sutfin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamara A. Sutfin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamara A. Sutfin more than expected).

Fields of papers citing papers by Tamara A. Sutfin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamara A. Sutfin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamara A. Sutfin. The network helps show where Tamara A. Sutfin may publish in the future.

Co-authorship network of co-authors of Tamara A. Sutfin

This figure shows the co-authorship network connecting the top 25 collaborators of Tamara A. Sutfin. A scholar is included among the top collaborators of Tamara A. Sutfin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tamara A. Sutfin. Tamara A. Sutfin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Raising High-Density Lipoprotein in Humans Through Inhibition of Cholesteryl Ester Transfer Protein 2004 ·Arteriosclerosis Thrombosis and Vascular Biology ·Ronald W. Clark, Tamara A. Sutfin, Roger B. Ruggeri, (unknown), Eliot Sugarman, (unknown), Patricia G. Cosgrove, Thomas Sand, Ronald T. Wester, John A. Williams, Michael E. Perlman, M J Bamberger	283
2	Pharmacokinetics and Pharmacodynamics of Extended‐Release Glipizide GITS Compared with Immediate‐Release Glipizide in Patients with Type II Diabetes Mellitus 2002 ·The Journal of Clinical Pharmacology ·Menger Chung, IONE A. KOURIDES, William Canovatchel, Tamara A. Sutfin, Michael Messig, Rochelle L Chaiken	27
3	Comparative Efficacy of a Once-Daily Controlled-Release Formulation of Glipizide and Immediate-Release Glipizide in Patients With NIDDM 1994 ·Diabetes Care ·Michael Berelowitz, Christine T. Fischette, William T. Cefalu, David S. Schade, Tamara A. Sutfin, IONE A. KOURIDES	41
4	The effect of felodipine on bile flow in pentobarbital anaesthetized rats and conscious rats receiving bile salt supplementation 1992 ·European Journal of Drug Metabolism and Pharmacokinetics ·(unknown), Tamara A. Sutfin, C G Regårdh	2
5	Biliary secretion of felodipine metabolites in man after intravenous [14C]felodipine 1990 ·European Journal of Clinical Pharmacology ·Tamara A. Sutfin, Tore Lind, Margareth Gabrielsson, (unknown)	12
6	Stereoselective Interaction of Omeprazole with Warfarin in Healthy Men 1989 ·Therapeutic Drug Monitoring ·Tamara A. Sutfin, (unknown), Hans Boström, Sven Eriksson, Peter Höglund, Otto Paulsen	113
7	Contribution of the intestine to the first-pass metabolism of felodipine in the rat. 1989 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown), Tamara A. Sutfin, (unknown), C G Regårdh	20
8	Multiple-Dose Pharmacokinetics of Imipramine and Its Major Active and Conjugated Metabolites in Depressed Patients 1988 ·Journal of Clinical Psychopharmacology ·Tamara A. Sutfin, Giulia Perini, George Molnar, William J. Jusko	29
9	Effects of biliary excretion on the disposition of felodipine and metabolites in the rat 1987 ·Xenobiotica ·Tamara A. Sutfin, Margareth Gabrielsson, C G Regårdh	7
10	Liquid-chromatographic determination of eight tri- and tetracyclic antidepressants and their major active metabolites. 1984 ·Clinical Chemistry ·Tamara A. Sutfin, Raffaele D’Ambrosio, W J Jusko	24
11	The analysis and disposition of imipramine and its active metabolites in man 1984 ·Psychopharmacology ·Tamara A. Sutfin, C. Lindsay DeVane, William J. Jusko	32
12	Active metabolites of imipramine and desipramine in man 1982 ·Clinical Pharmacology & Therapeutics ·William Z. Potter, Helena Maria Calil, Tamara A. Sutfin, Anthony P. Zavadil, William J. Jusko, Judith L. Rapoport, Frederick K. Goodwin	79
13	High‐Performance Liquid Chromatographic Assay for Imipramine, Desipramine, and Their 2‐Hydroxylated Metabolites 1979 ·Journal of Pharmaceutical Sciences ·Tamara A. Sutfin, William J. Jusko	59

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact